首页|具有防治脑缺血再灌注损伤的中药有效成分研究进展

具有防治脑缺血再灌注损伤的中药有效成分研究进展

扫码查看
脑卒中是我国成年人致死、致残的首要原因,目前治疗缺血性脑卒中的关键为恢复缺血脑组织的缺血再灌注,主要手段为静脉溶栓,而缺血后再灌注可能会引起进一步的神经性损伤,即脑缺血再灌注损伤(cerebral is-chemia-reperfusion injury,CIRI)。脑缺血再灌注损伤严重危害人类健康且涉及多个级联反应,病理机制复杂。中药具有多组分、多靶点、多途径的特点,对脑缺血再灌注损伤有着巨大的治疗潜力。本文综述了具有防治脑缺血再灌注损伤作用的中药有效成分,以期为脑缺血再灌注损伤的病理研究提供依据,同时为中药防治脑缺血再灌注损伤的临床应用提供更多参考。
Research progress in active ingredients of traditional Chinese medicine prevention and treatment of cerebral ischemia reperfusion injury
Stroke is the prime cause of death and disability in adults in China.The crucial key to treating ischemic stroke at present is to restore ischemia-reperfusion to ischemic brain tissues,and the main means is intravenous thrombolysis.However,reperfusion after ischemia may cause further neurological damage,i.e.cerebral ischemia-reperfusion injury(CIRI).Cerebral ischemia reperfusion injury(CIRI)is a serious hazard to human health.The mechanism of CIRI involves multiple cascade reactions and complex pathological mechanisms.Traditional Chinese medicine(TCM)has the characteristics of multi-component,multi-target and multi-pathway,which has great potential in prevention and treatment of CIRI.This article reviews the research progress of active ingredients of TCM,in order to provide theoretical basis for the pathological study of cerebral ischemia-reperfusion injury and provide reference for the clinical application of traditional Chinese medicine.

Cerebral ischemia reperfusion injuryActive ingredients of traditional Chinese medicineNeuroprotectionAction mechanism

刘莹、祝琳琳、尤诗晴、徐畅、褚福浩、刘斌、张薇

展开 >

北京中医药大学中药学院,北京 102488

齐鲁理工学院,山东 济南 250200

国家中医药管理局中药经典名方有效物质发现重点研究室,北京 102488

脑缺血再灌注损伤 中药有效成分 神经保护 作用机制

国家自然科学基金项目

81803587

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(8)